FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Tuesday

 

Muddy fund-raiser benefits multiple sclerosis charity

























Participants in the 2014 MuckFest MS Boston course set up in the Devens area.

Two years ago, Lisa Kennedy’s health was failing, and the Maynard resident knew she had to make serious lifestyle changes.
Read more »

 

MS treatment using stem cells shows promise compared to medication



















New research from Italy and Spain demonstrated that intense immunosuppression followed by autologous hematopoietic stem cell transplantation (AHSCT) was better than the medication mitoxantrone in treating severe cases of multiple sclerosis. The study appeared in the February 11, 2015, online issue of Neurology.
Read more »

Labels: ,


 

Statins for Multiple Sclerosis





















A new meta-analysis and review of statins for multiple sclerosis has just been published, and it seemed like a good opportunity to take a look at what scientists say about statins for MS. It also would be enlightening to hear from people with multiple sclerosis concerning their experiences and opinions about using these drugs.
Read more »

Labels:


 

Utilization and Patients’ Perceptions of the Effectiveness of Pain Treatments in Multiple Sclerosis: A Cross-sectional Survey: STUDY

 

Randomized trial of vaccination in Gilenya (fingolimod) treated patients with multiple sclerosis: STUDY

Monday

 

iConquerMS seeks people with MS to create patient- powered research network


























iConquerMS™ is seeking to create a patient-powered research network that includes at least 20,000 people with MS who contribute data on their health and other topics. Survey data will be made available to research scientists who are studying MS and similar diseases. Through the iConquerMS.org website/portal, people living with MS submit large amounts of health data that can be used by researchers to find patterns that might not be visible otherwise. These patterns and insights may help researchers figure out the causes of MS, determine who will respond best to various therapies, and find new, improved treatments for the disease.
Read more »

 

Medical Alert: MS Awareness: VIDEO




















Mark Roeder with National Multiple Sceleoris Society and Dr. Peter Calabresi from Johns Hopkins MS Center talk about awareness.
Click here to see more

Labels:


 

New imaging technique reveals MS progression related to diffustivity in brain



































Scientists are developing new tools to understand multiple sclerosis pathogenesis and monitor the benefits of treatments. One of these tools is diffusion tensor imaging (DTI), a novel technique that describes the microstructural organization of white matter tracts in the brain. Although DTI has greater pathological specificity than magnetic resonance imaging (MRI), certain aspects of the technique are still in progress.
Read more »

 

New MS educational program seeks to improve care in women
















This week the Consortium of Multiple Sclerosis Centers (CMSC) in collaboration with The France Foundation, a provider of continuing medical education have launched a new educational program focused on the important issues that affect women with multiple sclerosis (MS), entitled, “Strategies to Improve the Care of MS in Women.”  
Read more »

 

Alteration profile of executive functions in multiple sclerosis: STUDY

Sunday

 

Walking for Wendy: VIDEO





























His bags are packed and he's buckled in.
Read more »

Labels:


 

Hundreds lap Lake Wendouree for Overcoming MS Walk























Overcoming MS walk: Professor George Jelinek proves there is hope for MS sufferers. PICTURE: JEREMY BANNISTER


A DIAGNOSIS of multiple sclerosis was the catalyst for Professor George Jelinek to become healthier.
Read more »

Labels:


 

Funding helps researchers to kiss Multiple Sclerosis (MS) goodbye


















Murdoch University researchers have received funding to investigate the link between the Epstein-Barr virus infection, more commonly known as glandular fever or the ‘kissing disease’, and the debilitating disease Multiple Sclerosis (MS).
Read more »

 

Neuroscience & Spine Center patients benefit from support of care navigator































Maureen Lall, Spine Care Navigator


The Neuroscience & Spine Center at Houston Methodist Sugar Land Hospital provides diagnosis and treatment for the widest possible range of neurological issues, including Alzheimer’s and memory disorders, amyotrophic lateral sclerosis (ALS), back and neck pain, brain and spinal tumors, epilepsy and seizures, migraines and headaches, multiple sclerosis (MS), muscle and nerve injuries, Parkinson’s disease and movement disorders, and stroke.
Read more »

 

Activities of Daily Living and Self-Care Agency in Patients with Multiple Sclerosis for the First 10 Years: STUDY
















Activities of Daily Living 
(Enhance your Eldershield. eldershield.weebly.com.)

Read more »

Labels:


Saturday

 

Harvest ninth grader's brain experiment takes 2nd in national contest; seeks cure for MS
















































Christian Gonzalez, 14, placed second in a national contest to design a brain experiment. His entry seeks to find a cure for multiple sclerosis. (Paul Huggins/phuggins@al.com)


While many of his 14-year-olds counterparts are worrying about acne, Christian Gonzalez is looking to cure multiple sclerosis.
Read more »

 

Milford fitness class leader deals with multiple sclerosis


























Kathy Cleveland photo
Kani Nicodemus shares a laugh with Joanne McCole during a Sunday morning spinning class at Hampshire Hills Sports & Fitness Club.


To watch Kani Nicodemus lead an early morning indoor cycling class, you would think she is as healthy as any of the other spinning teachers at Hampshire Hills Sports & Fitness Club.
Read more »

Labels: ,


 

New law to guarantee access for service dogs




























Pam Andrews has multiple sclerosis so her service dog Cyber helps her pick up things – such as the crutch Cyber is clutching – and pull open doors, among other duties. She’s thrilled at proposed new legislation that will include provisions to provide her and her dog access to businesses and other places, and fine those caught pretending their pets are service dogs.— Image Credit: Wanda Chow/NewsLeader

Pam Andrews and her daughter-in-law had driven an hour to take her then-two-year-old grandson to a regional tourist attraction from her home in Richmond.
Read more »

 

Fox’s Neil Cavuto Anchors Multiple Sclerosis Awareness Events

























March is a busy time for Americans, bringing St. Patrick’s Day and NCAA March Madness. Fox News and Fox Business Network anchor Neil Cavuto hopes people also will see March as Multiple Sclerosis Awareness Month.

A 30-year TV news vet, Cavuto has a personal stake in the promotion of MS Awareness: He was diagnosed with the disease in 1997, after beating stage-4 Hodgkin’s Disease in the ’80s.
Read more »

 

The beneficial effects of vitamin D3 on reducing antibody titers against Epstein–Barr virus in multiple sclerosis patients: STUDY

Friday

 

Men’s MS support group opens up: VIDEO
























Women make up the majority of patients affected by Multiple Sclerosis, two-thirds, so it’s not often you hear from the men with MS. A men’s support group at the Mandell MS Center at St. Francis in Hartford talks about their challenges with living with a disorder that affects the central nervous system.
Read more »

Labels:


 

Wheelchair-using speakers at a national disability conference had to be CARRIED on stage because there was no wheelchair access while the disabled toilets were being used for storage



































Speaker Deborah Haygarth, who has multiple sclerosis, was forced to get out of her wheelchair and carried by two people on and off the stage

'I thought 'They're going to pull out a ramp, they obviously planned for this',' she told Daily Mail Australia.
Read more »

Labels:


 

Multiple Sclerosis: Understanding and Communication Important







































The National Institutes of Health defines multiple sclerosis (MS) as "an unpredictable disease of the central nervous system.
Read more »

 

MS Patients Weigh In on Physician Conflicts of Interest in New Study































Multiple sclerosis (MS) is difficult enough for those who have it, causing damage to the nervous system, difficulty with movement, sensation, numbness, loss of vision and pain. People with MS rely on medications and the care of physicians to manage their symptoms and the progressions of the disease. But what happens when physicians entrusted to care for MS patients have conflicts of interest, due to connections with the pharmaceutical industry, such as possible perks provided by specific drug manufacturers? A new study focuses on how MS patients feel about physician conflicts of interest — and indicates that these types of relationships are in fact of concern to people with MS.
Read more »

Labels:


 

Physiological Factors Contributing to Mobility Loss Over 9 Years of Follow-Up—Results From the InCHIANTI Study: STUDY

Thursday

 

Curcumin and Multiple Sclerosis

























About five years ago I interviewed a young woman (let’s call her Rose) with multiple sclerosis who was managing the disease with natural remedies. One of those remedies was curcumin, a compound present in the curry spice called turmeric.
Read more »

 

Have researchers discovered the sound of the stars?





























Researchers from the University of Copenhagen are the first in the world to develop a secure way of measuring the important protein apo-M. This could prove relevant for research into diseases such as diabetes, arteriosclerosis and sclerosis.
Read more »

 

Low Dose Naltrexone Review for MS Reveals High Safety Profile, Mixed Results on Benefits in Multiple Studies



















One of the most widely disputed treatments for multiple sclerosis is low dose naltrexone (LDN). While a plethora of patient testimonies and anecdotal evidence suggest immense benefits of LDN for multiple sclerosis, many clinicians are wary due to the lack of FDA approval outside of treating heroin and alcohol addiction.
Read more »

 

Exercise may improve cognitive performance in people with relapsing-remitting multiple sclerosis: STUDY


























Cognitive impairment is a major debilitating feature of multiple sclerosis, and is estimated to occur in more than 50% of people living with MS at some point during the disease. These cognitive impairments can appear as difficulties with learning and memory, and deterioration of executive functions, such as planning or decision-making, focusing attention, multi-tasking, and problem-solving.
Read more »

Labels: ,


 

CXCL13 antibody for the treatment of autoimmune disorders: STUDY

Wednesday

 

Digmanns share 20 year experience with multiple sclerosis By Jacob Kahn


























Dan Digmann and his wife, Jennifer speak on behalf of National Multiple Sclerosis Awareness Month on March 17 UC Rotunda. They will speak about their personal journey in coping with and rising above Multiple Sclerosis.

Dan and Jennifer Digmann took Central Michigan University students and community members on a journey through their experience with multiple sclerosis Tuesday in the Bovee University Center, by asking the audience to imagine their life in 20 years.
Read more »

Labels:


 

Translational Medicine Consortium Grants $1.9 Million for MS Research



















The Strategic Pharma-Academic Research Consortium for Translational Medicine has awarded its first grants totaling more than $1.9 million to support research projects dedicated to autoimmune diseases. Among the recipients is researcher Yanjiao Zhou, Ph.D., who is leading a study at Washington University in St. Louis (WUSTL) focused on multiple sclerosis (MS), as announced in a press release.
Read more »

 

University of Cambridge's Alastair Compston wins 2015 John Dystel Prize for MS Research































Professor Alastair Compston


The American Academy of Neurology (AAN) and the National Multiple Sclerosis Society are awarding the 2015 John Dystel Prize for MS Research to Alastair Compston, MBBS, PhD, Professor of Neurology at the University of Cambridge.
Read more »

 

The Glycan Role in the Glycopeptide Immunogenicity Revealed by Atomistic Simulations and Spectroscopic Experiments on the Multiple Sclerosis Biomarker CSF114(Glc): STUDY

 

Immune parameters of patients treated with Nerventra (Laquinimod), a novel oral therapy for the treatment of multiple sclerosis: results from a double-blind placebo-controlled study: STUDY

Tuesday

 

Being diagnosed with multiple sclerosis: VIDEO





















People are most often diagnosed with multiple sclerosis or MS between the ages of 20 and 40. Everyone reacts differently to diagnosis. In this video people with MS talk about how they responded to their diagnosis.
Story Source: The above story is based on materials provided by NHSCHOICES
Note: Materials may be edited for content and length

Labels:


 

Things you can do for World MS Day: VIDEO
























World MS Day 2015 is coming up on May 27, and the first newsletter was emailed out on Sunday, March 15 to get people to help out all over the world.
Read more »

Labels:


 

Faces of MS: Diagnosed at 17, North Bergen woman finds a way to stay positive: SLIDESHOW































Kellie and her team at one of the annual MS Walks in Manhattan. courtesy of Kellie Barker

"It can be meningitis, a brain tumor, Lyme Disease or MS."
Read more »

Labels: ,


 

Multiple Sclerosis Eye Care Center Commemorates 10 Year Anniversary



















The Multiple Sclerosis Eye Center for Analysis, Research and Education (MS Eye CARE) is celebrating 10 years of expert eye care in improving diagnosis and treatment of multiple sclerosis (MS). The Center is the result of a collaboration between the University Eye Institute at the University of Houston’s College of Optometry and the National Multiple Sclerosis Society.
Read more »

 

Walking Distance as a Predictor of Falls in People With Multiple Sclerosis: STUDY

Monday

 

New treatment for multiple sclerosis slows disease prog­ression, reduces relapses




















Lisa Kapps

A groundbreaking new treatment for multiple sclerosis is now available in the United States and is being used to treat patients in San Antonio.
Read more »

Labels:


 

Spinal Cord Protein Possible Drug Target for Multiple Sclerosis




























A spinal cord change has been discovered and could be a target for new multiple sclerosis (MS) medications, according to findings published in the Annals of Clinical and Translational Neurology.
Read more »

 

MS walk photo gallery: SLIDESHOW

 

Multiple Sclerosis Diagnosis and Treatment Explained by Doctor Kevin Most





















Everyone knows that nerves are the pathway for information to our brain, to muscles and to many other areas in the body. The nerves have a protective layer  that surrounds them. Think of an electric cable, it has rubber around it and in the middle is a metal that allows for the energy to flow from one point to another. We have the same thing with nerves in our body, they have a protective layer called Myelin.
Read more »

Labels:


 

A personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort: STUDY

Sunday

 

Could This Study Help Lead to a Cure for Select Multiple Sclerosis Patients?





























For a disease that affects 2.5 million people around the globe and more than 400,000 people in the United States, it's a shame that so little is known about multiple sclerosis despite the amount of money being put into research of the disease.
Read more »

Labels:


 

A New Multiple Sclerosis Treatment On The Horizon? Anti-Inflammatory Molecule May Halt Disease
















































A group of researchers from Walter and Eliza Hall Institute have developed a new potential drug-like molecule that is capable of halting inflammation in the progression of multiple sclerosis (MS), a debilitating disease that has no cure.
Read more »

 

Medical pot patients keep waiting as legal challenges further delay program: VIDEO






















Marla Levi


A year and a half after Illinois lawmakers voted to legalize medical marijuana, Marla Levi is still waiting.
Read more »

Labels: ,


 

Newfoundland and Labrador funds treatment with AUBAGIO™ for Relapsing Remitting Multiple Sclerosis






























Genzyme, a Sanofi company, announced today that the Newfoundland and Labrador Prescription Drug Program (NLPDP) has included AUBAGIO™ (teriflunomide) 14 mg on the provincial drug formulary as a first-line oral agent for people in the province living with relapsing remitting multiple sclerosis (RRMS).
Read more »

Labels:


 

Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate: STUDY


Go to Newer News Go to Older News